All News #Library
Others
YolTech Sells China Rights Of Cholesterol Gene Editing Therapy To Salubris
27 Aug 2024 //
FIERCE BIOTECH
First Patient Dosed in Phase I Clinical Trial of YOLT-201
11 Jul 2024 //
PR NEWSWIRE

Market Place
Sourcing Support